STOCK TITAN

VIR (NASDAQ: VIR) insider notice: 1,616 vested shares; 2,089 sold

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

VIR filed a Form 144 notice reporting proposed sales of common stock by an insider. The filing lists 1,616 common shares associated with restricted stock vesting on 02/23/2026 and records 2,089 common shares listed under securities sold during the past three months on 02/23/2026 by Mark D. Eisner.

The transactions are tied to compensation-related vesting and a broker-dealer record for Fidelity Brokerage Services LLC appears on 02/24/2026.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 shows insider-linked sales tied to restricted stock vesting.

The filing lists 1,616 common shares described as resulting from restricted stock vesting on 02/23/2026, indicating the shares became eligible for sale as part of compensation settlement. The filing also reports 2,089 common shares sold by Mark D. Eisner on 02/23/2026.

These items are administrative disclosures of an insider transaction; cash-flow treatment and net proceeds details are not included in the provided excerpt. Subsequent filings or broker confirmations would show execution details if available.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does VIR's Form 144 say about shares to be sold?

The Form 144 lists 1,616 common shares tied to restricted stock vesting on 02/23/2026. It records that these shares became eligible for sale as part of compensation-related vesting; the excerpt does not state execution timing or proceeds.

How many shares did Mark D. Eisner report selling for VIR?

The filing shows 2,089 common shares listed under securities sold during the past three months on 02/23/2026. This entry appears in the insider sales section; the excerpt does not include sale price or net proceeds information.

Is the VIR Form 144 tied to a broker-dealer?

Yes—Fidelity Brokerage Services LLC is listed with a record date of 02/24/2026. The broker-dealer entry appears alongside the securities information, consistent with standard brokerage handling of insider transactions.

Are the shares in the Form 144 from compensation or open-market sales?

The excerpt indicates 1,616 shares resulted from restricted stock vesting (compensation) on 02/23/2026. The 2,089-share entry for Mark D. Eisner is in the sold-in-past-three-months section, but the excerpt does not specify method (open-market or other).

Does the Form 144 disclose proceeds or sale prices for VIR transactions?

The provided excerpt does not include sale prices or aggregate proceeds. It lists share counts and dates tied to vesting and prior sales, but execution price and cash-flow details are not present in the excerpt.
Vir Biotechnology, Inc.

NASDAQ:VIR

View VIR Stock Overview

VIR Rankings

VIR Latest News

VIR Latest SEC Filings

VIR Stock Data

1.35B
126.52M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SAN FRANCISCO